New hope for chinese cancer patients: targeted drug Dato-DXd enters trials
NCT ID NCT05460273
First seen Mar 11, 2026 · Last updated May 23, 2026 · Updated 15 times
Summary
This study tests a new drug called Dato-DXd in Chinese patients with advanced non-small-cell lung cancer or triple-negative breast cancer that has spread or stopped responding to treatment. The drug works by attaching to cancer cells and blocking their growth. About 119 participants will receive an injection every three weeks until their cancer worsens. The goal is to see how well the drug shrinks tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Beijing, 100039, China
-
Research Site
Beijing, 100044, China
-
Research Site
Beijing, 100142, China
-
Research Site
Bengbu, 233004, China
-
Research Site
Changchun, 130012, China
-
Research Site
Changchun, 130021, China
-
Research Site
Chengdu, 610000, China
-
Research Site
Chongqing, 400030, China
-
Research Site
Dalian, 116023, China
-
Research Site
Fuzhou, 350001, China
-
Research Site
Guangzhou, 510060, China
-
Research Site
Guangzhou, 510100, China
-
Research Site
Hangzhou, 310022, China
-
Research Site
Harbin, 150081, China
-
Research Site
Jinan, 250030, China
-
Research Site
Jinan, 250117, China
-
Research Site
Nanchang, 330006, China
-
Research Site
Nanchang, 330009, China
-
Research Site
Shenyang, 110042, China
-
Research Site
Wuhan, 430022, China
-
Research Site
Wuhan, 430030, China
Conditions
Explore the condition pages connected to this study.